Human Papillomavirus Vaccination After COVID-19

The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to derail the uptake of human papillomavirus (HPV) vaccination in low- and lower-middle income countries with major disruptions to routine immunization and the introduction of new vaccines delayed. This has a major impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Toh, Zheng Quan, Russell, Fiona M, Garland, Suzanne M, Mulholland, Edward K, Patton, George, Licciardi, Paul V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962726/
https://www.ncbi.nlm.nih.gov/pubmed/33748668
http://dx.doi.org/10.1093/jncics/pkab011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962726/
https://www.ncbi.nlm.nih.gov/pubmed/33748668
http://dx.doi.org/10.1093/jncics/pkab011

Ejemplares similares